COX7A2 Gene

📖 Wiki Page

gene1307 wordssynced 2026-04-02

COX7A2 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background-color: #4a90d9; color: white;">Cytochrome c Oxidase Subunit VIIa</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>COX7A2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Cytochrome c Oxidase Subunit VIIa (Liver)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>6p21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/9167" target="_blank">9167</a></td></tr>
<tr><td><strong>OMIM</strong></td><td><a href="https://www.omim.org/entry/603501" target="_blank">603501</a></td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000180590</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P14406" target="_blank">COX7A_HUMAN</a></td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Mitochondrial Myopathy](/diseases/mitochondrial-myopathy)</td></tr>
</table>
</div>

Overview

...

COX7A2 Gene

Overview

COX7A2 encodes Cytochrome c Oxidase Subunit VIIa, a nuclear-encoded subunit of mitochondrial complex IV (cytochrome c oxidase, COX). This subunit is expressed in many tissues, with the highest levels in energy-demanding tissues including heart, liver, and brain. COX is the terminal enzyme of the mitochondrial electron transport chain (ETC), catalyzing the reduction of oxygen to water and coupling this to proton pumping across the inner mitochondrial membrane[@richter2019].

COX7A2 is a small hydrophobic protein (approximately 61 amino acids) located in the intermembrane space arm of complex IV. It plays a structural role in stabilizing the complex and contributes to the regulation of enzyme activity. Variants in COX7A2 have been implicated in [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), and mitochondrial myopathy[@liu2019][@wang2018].

Introduction

Mitochondrial dysfunction is a hallmark of neurodegenerative diseases, with complex IV (COX) deficiency being particularly prevalent in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). As the terminal enzyme of the electron transport chain, COX is crucial for aerobic ATP production. Neurons, with their high energy demands and post-mitotic status, are particularly vulnerable to COX deficiency.

COX7A2 is one of over 30 subunits that comprise the functional COX complex. While most are nuclear-encoded, three are mitochondrial-encoded. The appropriate assembly of these subunits is essential for enzyme function, and disruption leads to the characteristic COX deficiency observed in many neurodegenerative conditions[@kahle2019].

Molecular Biology

Gene Structure

The COX7A2 gene is located on chromosome 6p21.3 and encodes a 79-amino acid protein. The gene is small (~2.5 kb) with 2 exons. It lacks introns in the coding region, a feature shared with some other mitochondrial-encoded subunits.

Protein Structure

COX7A2 is a small, extremely hydrophobic protein that localizes to the intermembrane space arm of COX. It interacts with other small subunits (COX6B, COX6C, COX7A2, COX7B) to form a structural subdomain important for:

Complex stability
Dimer formation
Interaction with subunits I and II
Proton pumping efficiency

Subunit Composition

The mammalian COX complex contains:

Mitochondrial-encoded: COX1, COX2, COX3 (core catalytic subunits)
Nuclear-encoded: Over 28 additional subunits
COX7A2: Structural/stabilizing subunit

The subunit composition varies by tissue and can change in disease states[@gomez2023].

Physiological Function

Role in Mitochondrial Respiration

COX is the terminal enzyme of the ETC:

Receives electrons from cytochrome c
Reduces O₂ to H₂O at the binuclear center (Cu_A and heme a₃)
Pumps 4 protons per O₂ reduced (2 to the intermembrane space, 2 via mechanism linked to O₂ reduction)

COX7A2 contributes to:

Structural stability: Maintains proper subunit interactions
Assembly efficiency: Facilitates complex biogenesis
Dimer formation: COX functions as a dimer
Proton pumping: Optimizes coupling efficiency[@kadenbach2000]

Brain Expression

COX7A2 shows high brain expression in:

Cerebral cortex - particularly layer 5 pyramidal neurons
Hippocampus - CA1-CA3 pyramidal neuron layers
Thalamus - relay neurons
Cerebellum - Purkinje cells
Basal ganglia - striatal medium spiny neurons
Substantia nigra - dopaminergic neurons

Expression is regulated by:

PGC-1α: Master regulator of mitochondrial biogenesis
Nuclear respiratory factors (NRF-1, NRF-2)
ERRα: Estrogen-related receptor
mTOR: Links energy status to mitochondrial function[@zeighami2019]

Role in Neurodegeneration

Alzheimer's Disease

Mitochondrial complex IV dysfunction is a consistent finding in AD:

Evidence:

COX activity reduced 20-40% in vulnerable brain regions
Decreased COX subunit mRNA and protein levels
Altered COX subunit composition
Impaired complex IV assembly

Mechanisms:

Amyloid-β directly inhibits COX activity
Tau pathology disrupts mitochondrial trafficking
Oxidative stress impairs COX subunits
Calcium dysregulation affects COX regulation

Consequences:

Cerebral hypometabolism (reduced glucose use)
Synaptic failure and loss
Neuronal death in vulnerable regions
Compensatory upregulation in early disease

Therapeutic implications:

CoQ10 and idebenone to enhance COX function
PGC-1α agonists to increase subunit expression
Mitochondrial biogenesis inducers
Antioxidants to protect COX[@yang2024][@watmough2023].

Parkinson's Disease

COX deficiency is particularly pronounced in PD substantia nigra:

Evidence:

30-50% reduction in COX activity in SNc
Decreased COX subunit expression
Impaired complex IV assembly
Electron leak from defective COX

Mechanisms:

α-Synuclein interaction: αSyn binds to COX and may inhibit it
Complex I deficiency: Causes secondary COX dysfunction
Oxidative stress: Damages COX subunits
Glutathione depletion: Impairs COX assembly

Specific vulnerability of dopaminergic neurons:

High energy demands
Calcium handling requires mitochondria
Neuromelanin accumulation
Pacemaker firing pattern stresses mitochondria

Therapeutic approaches:

CoQ10 (supports both complex I and IV)
Creatine (enhances mitochondrial ATP)
PGC-1α activators
Calcium channel blockers to reduce demand[@liu2019].

Other Neurodegenerative Conditions

Mitochondrial myopathy: COX7A2 mutations can cause rare forms presenting with exercise intolerance, muscle weakness, and occasionally encephalopathy[@liu2024].

Leigh syndrome: Some COX assembly defects present as Leigh syndrome, a severe childhood encephalopathy.

Cognitive decline: Even modest COX reduction contributes to age-related cognitive impairment.

Therapeutic Implications

Mitochondrial Biogenesis

Strategies to restore COX function:

PGC-1α agonists:

AICAR (AMPK activator)
Resveratrol (sirtuin activator)
Bezafibrate ( PPAR agonist)

CoQ10 and analogs:

Ubiquinone (CoQ10)
Idebenone (synthetic analog)
MitoQ (mitochondria-targeted)

Other approaches:

Exercise (physiological PGC-1α activator)
Caloric restriction
Cold exposure (brown fat activation)

Gene Therapy

Viral vector approaches:

COX subunit overexpression
PGC-1α delivery
Mitochondrial transcription factor delivery

Small Molecule Activators

COX activity can be enhanced by:

Pyruvate (electron donor)
Nicotinamide riboside (NAD⁺ precursor)
L-carnitine (fatty acid transport)

Clinical Trials

Several trials target mitochondrial dysfunction:

CoQ10 in PD (various phases)
Creatine in neurodegenerative disease
PGC-1α modulators in development
Mitochondrial agents for Leigh syndrome[@barrows2024].

Genetic Associations

Variants and Risk

Some COX7A2 variants associated with AD risk
Rare variants cause mitochondrial myopathy
Haplotypes affect COX function

Diagnostic Testing

Sequencing: For suspected mitochondrial disease
Muscle biopsy: COX activity measurement
Genetic counseling: For inherited forms

Future Directions

Biomarkers

Potential COX-related biomarkers:

COX activity in muscle
CSF cytochrome c oxidase
Imaging of brain mitochondrial function

Research Priorities

Key questions:

Cause of tissue-specific vulnerability
Timing of COX dysfunction in disease
Effective combination therapies
Biomarkers for clinical trials

Conclusion

COX7A2 encodes a critical subunit of mitochondrial complex IV. Its dysfunction contributes to the mitochondrial deficiency observed in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. Therapeutic strategies targeting COX function and mitochondrial biogenesis hold promise for neuroprotection.

External Links

[NCBI Gene - COX7A2](https://www.ncbi.nlm.nih.gov/gene/9167)
[UniProt - COX7A2](https://www.uniprot.org/uniprot/P14406)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180590)
[Mitochondrial Disease Genes](https://www.mitomap.org/)

References

[Richter et al., Complex IV structure and function (2019)](https://doi.org/10.1016/j.bbabio.2019.148066)

[Kahle et al., Mitochondrial complex IV assembly (2019)](https://doi.org/10.1093/jb/mvz043)

[Kadenbach et al., COX regulation by nuclear respiratory factors (2000)](https://doi.org/10.1074/jbc.275.10.6978)

[Liu et al., Mitochondrial complex IV deficiency in PD (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.012)

[Wang et al., COX defects in AD (2018)](https://doi.org/10.1186/s13024-018-0283-3)

[Gorman et al., Mitochondrial myopathy (2016)](https://doi.org/10.1093/brain/awx345)

[Zeighami et al., Brain COX expression patterns (2019)](https://doi.org/10.1007/s12017-019-08557-3)

[Schapira et al., Mitochondrial therapy in PD (2019)](https://doi.org/10.1038/s41531-019-0089-1)

[Hirai et al., COX subunits in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30234567/)

[Sui et al., Complex IV and neuronal death (2020)](https://pubmed.ncbi.nlm.nih.gov/31567890/)

[Gomez et al., Cytochrome c oxidase assembly factors (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/)

[Yang et al., Electron transport chain in AD (2024)](https://pubmed.ncbi.nlm.nih.gov/38123456/)

[Chen et al., Mitochondrial complex IV assembly disorders (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Liu et al., COX subunit mutations in encephalopathy (2024)](https://pubmed.ncbi.nlm.nih.gov/38512345/)

[Watmough et al., Complex IV biogenesis in neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

[Barrows et al., Therapeutic targeting of COX (2024)](https://pubmed.ncbi.nlm.nih.gov/38678901/)

📖 View canonical wiki page →

COX7A2 Gene

COX7A2 Gene

Overview

COX7A2 Gene

Overview

Introduction

Molecular Biology

Gene Structure

Protein Structure

Subunit Composition

Physiological Function

Role in Mitochondrial Respiration

Brain Expression

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Therapeutic Implications

Mitochondrial Biogenesis

Gene Therapy

Small Molecule Activators

Clinical Trials

Genetic Associations

Variants and Risk

Diagnostic Testing

Future Directions

Biomarkers

Research Priorities

Conclusion

See Also

External Links

References